Back to Search Start Over

Binding and inhibition of the ternary complex factor Elk-4/Sap1 by the adapter protein Dok-4.

Authors :
Hooker, Erika
Baldwin, Cindy
Roodman, Victoria
Batra, Anupam
Naajia Nur Isa
Tomoko Takano
Lemay, Serge
Source :
Biochemical Journal. 5/1/2017, Vol. 474 Issue 9, p1509-1528. 20p.
Publication Year :
2017

Abstract

The adapter protein Dok-4 (downstream of kinase-4) has been reported as both an activator and inhibitor of Erk and Elk-1, but lack of knowledge about the identity of its partner molecules has precluded any mechanistic insight into these seemingly conflicting properties. We report that Dok-4 interacts with the transactivation domain of Elk-4 through an atypical phosphotyrosine-binding domain-mediated interaction. Dok-4 possesses a nuclear export signal and can relocalize Elk-4 from nucleus to cytosol, whereas Elk-4 possesses two nuclear localization signals that restrict interaction with Dok-4. The Elk-4 protein, unlike Elk-1, is highly unstable in the presence of Dok-4, through both an interaction-dependent mechanism and a pleckstrin homology domain-dependent but interaction- independent mechanism. This is reversed by proteasome inhibition, depletion of endogenous Dok-4 or lysine-to-arginine mutation of putative Elk-4 ubiquitination sites. Finally, Elk-4 transactivation is potently inhibited by Dok-4 overexpression but enhanced by Dok-4 knockdown in MDCK renal tubular cells, which correlates with increased basal and EGF-induced expression of Egr-1, Fos and cylcinD1 mRNA, and cell proliferation despite reduced Erk activation. Thus, Dok-4 can target Elk-4 activity through multiple mechanisms, including binding of the transactivation domain, nuclear exclusion and protein destabilization, without a requirement for inhibition of Erk. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02646021
Volume :
474
Issue :
9
Database :
Academic Search Index
Journal :
Biochemical Journal
Publication Type :
Academic Journal
Accession number :
123066824
Full Text :
https://doi.org/10.1042/BCJ20160832